1D
4.94%
0.33%
1W
3.51%
0.73%
1M
0.76%
0.92%
YTD
1.47%
-1.02%
1Y
144.71%
9.1%
3Y
178.04%
39%
5Y
250.9%
64.39%
10Y
85.98%
255.01%
- Stock Absolute Returns
- Absolute Returns
Total Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.64%
0%
7.64%
6 Months
52.91%
0%
52.91%
1 Year
144.71%
0%
144.71%
2 Years
79.25%
0%
79.25%
3 Years
178.04%
0%
178.04%
4 Years
157.51%
0%
157.51%
5 Years
250.9%
0%
250.9%
Concord Drugs for the last several years.
What is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers 
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods
3
Quartile
QTD
-3.31%
3
Quartile
Sep-Dec
23.66%
1
Quartile
Jun-Sep
61.27%
2
Quartile
1Y
133.19%
2
Quartile
2025
117.05%
4
Quartile
2024
-36.37%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry 
Inconsistent Performance
Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods
2
Quartile
QTD
-3.31%
1
Quartile
Sep-Dec
23.66%
1
Quartile
Jun-Sep
61.27%
1
Quartile
1Y
133.19%
1
Quartile
2025
117.05%
4
Quartile
2024
-36.37%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap 
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available






